Gene · 9261
Papers3,346
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,346
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ROCK signaling at the crossroads of redox stress, mitochondrial dynamics, and metabolic disease. | Redox Biol | 2026 | 41791289 | PubTator, text mining | PubMed |
| Expression of Concern: The p38 MAPK-MK2 Axis Regulates E2F1 and FOXM1 Expression after Epirubicin Treatment. | Mol Cancer Res | 2026 | 41773013 | PubTator, text mining | PubMed |
| Timescale-dependent Phosphoproteomic Remodeling and Motility-associated Adaptation under Chronic Cabozantinib Exposure in Renal Cell Carcinoma. | Cancer Genomics Proteomics | 2026 | 41771580 | PubTator, text mining | PubMed |
| Inflammatory mechanisms underlying early Alzheimer's disease pathology: evidence from the aging rhesus macaque brain. | Front Cell Neurosci | 2026 | 41767744 | PubTator, text mining | PubMed |
| Diterpene Molecular Glue Stabilizes Protein-Protein Interactions of a Disordered Phosphoprotein that Controls Translational Repression. | JACS Au | 2026 | 41755863 | PubTator, text mining | PubMed |
| Molecular Pathways Driving Corneal Neovascularization in Herpes Simplex Keratitis. | Pathogens | 2026 | 41754438 | PubTator, text mining | PubMed |
| Plant-Derived Bioactive Compounds in Inflammation-Related Cancers: Mechanisms and Therapeutic Potential. | Plants (Basel) | 2026 | 41754282 | PubTator, text mining | PubMed |
| Hesperetin, Acting Through Inhibition of c-Jun Signaling, Mitigates Hypomyelinating Disease-Associated Stop-Loss Claudin-11-Induced Defective Morphogenesis in Oligodendroglial FBD-102b Cells. | Int J Mol Sci | 2026 | 41752091 | PubTator, text mining | PubMed |
| Signatures of Pancreatic Ductal Adenocarcinoma Uncovered by Integrative Multi-Omics Analysis. | Cancers (Basel) | 2026 | 41749940 | PubTator, text mining | PubMed |
| Advances in the Understanding of Akt Signaling in Cancers and the Potential of Inhibiting Akt-Driven Tumors Using Small Molecule Inhibitors: An Overview. | Cancers (Basel) | 2026 | 41749835 | PubTator, text mining | PubMed |
| Rewriting the viral script: post-translational modifications orchestrating SARS-CoV-2 pathogenesis and immune evasion. | Front Microbiol | 2026 | 41743132 | PubTator, text mining | PubMed |
| THBS1 upregulation by KLF7 in hypopharyngeal squamous cell carcinoma contributes to lung metastasis through the p38 MAPK signaling. | iScience | 2026 | 41732256 | PubTator, text mining | PubMed |
| Research progress on mitochondria in bone defect repair: mechanisms and therapeutic implications. | Front Bioeng Biotechnol | 2026 | 41725955 | PubTator, text mining | PubMed |
| Starvation-induced LHFPL3-AS2 promotes MAPKAP K2-dependent phosphorylation of hnRNPA0 and progression of esophageal squamous cell carcinoma. | Cancer Lett | 2026 | 41707979 | PubTator, text mining | PubMed |
| Metabolic stress conditions dictate MAPKAPK2-dependent efficiency of MEK1/2 inhibition in colorectal carcinoma. | Proc Natl Acad Sci U S A | 2026 | 41662531 | PubTator, text mining | PubMed |
| Radiotherapy enhances M1 macrophage immunogenic activity through IFNs induction and stimulation in TP53-wild type tumors. | Cancer Immunol Immunother | 2026 | 41653234 | PubTator, text mining | PubMed |
| MAPKAP Kinase 2 Orchestrates Memory T Cell Inflation in Cytomegalovirus Infection. | bioRxiv | 2026 | 41648230 | PubTator, text mining | PubMed |
| High-throughput assay for measuring target occupancy of covalent compounds: a case study with MK2. | RSC Chem Biol | 2026 | 41647276 | PubTator, text mining | PubMed |
| Enhancing the efficacy of VEGF inhibitors by co-inhibition of HIF in the treatment of glioblastoma. | Apoptosis | 2026 | 41575610 | PubTator, text mining | PubMed |
| SLC39A10 drives M2 macrophage polarization and gastric cancer progression through the MAPK14(p38α) pathway. | iScience | 2026 | 41536985 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9261/papers?page=2